Study of the INSPIRIS RESILIA Aortic Valve in real-world use
Part of Heart & circulation clinical trials.
This study collects information on people who receive the INSPIRIS RESILIA aortic valve as part of their regular care. Researchers want to see how well the valve works in everyday practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have your aortic valve replaced with the INSPIRIS RESILIA valve.
- You have had standard imaging tests (like an echocardiogram or CT scan) before the procedure.
- You are 18 years or older.
- You are willing and able to give written permission (informed consent) to be part of the study.
- You do not have an active infection in your heart (endocarditis or myocarditis) or have had one in the last 3 months.
- You are not having an emergency heart valve surgery, and you are not having another heart valve procedure at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how well a new artificial aortic valve and aorta graft (called KONECT RESILIA) work after surgery in real-world patients. Researchers want to understand if it's safe and performs well over time in people who need this valve replaced.
This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.
This study is testing a new generation of biologic (tissue) replacement valves for the aortic valve in adults aged 18 to 65. It aims to see how well these newer devices work compared to standard options.
This study follows patients with severe aortic stenosis who get a new heart valve (the SAPIEN 3 Ultra RESILIA) through a less invasive procedure (TAVR). Researchers want to see how well this valve works over time using special heart ultrasound tests.
This trial is testing a replacement valve (called MITRIS) for people whose own mitral valve or a previous artificial valve is not working well. The goal is to see how well the valve works over time after it is implanted.
This study is testing a new heart valve called the SAPIEN 3 Ultra RESILIA valve for people with severe aortic stenosis. Researchers want to see how well it works and how safe it is over 10 years after a minimally invasive valve replacement procedure called TAVI.
Hear when a new Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.